“…The most probable interaction site of the LBHM-driven model, as identified by the MOE Site finder module, included most of the reported residues involved in the antagonist binding (see the mutagenesis data). 32 The binding cavity reorganization induced by ligand interaction was caused by quite a conformational change of a number of amino acid side chains, belonging to TM3, TM4 and TM5 (volume = 1813 Å 3 ). More in detail, the antagonist SR144528 binding site included the following residues: (i) L107, I110, G111, T114, M115 and T118 in TM3; (ii) L160, S161, L163, V164, S165, P168, L169 in TM4 and (iii) Y190, L191, W194, L195, F197, I198, F202 in TM5.…”